Improved Outcomes in Men with Advanced Prostate Cancer.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 28745978)

Published in N Engl J Med on July 27, 2017

Authors

Christopher J Logothetis¹

Author Affiliations

1: From the University of Texas M.D. Anderson Cancer Center, Houston.

Articles cited by this ↗

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med (2017) 4.48

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med (2017) 1.43